Page last updated: 2024-08-24

topotecan and Radiation Pneumonitis

topotecan has been researched along with Radiation Pneumonitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, N; Chen, D; Feng, Q; Hui, Z; Ji, Z; Liang, J; Liu, L; Lyu, J; Wang, J; Wang, L; Wang, X; Xiao, Z; Yin, W; Zhang, H; Zhou, Z1
Ji, W; Lü, JM; Ou, GF; Ren, H; Wang, LH; Wang, XZ; Yin, WB; Zhou, ZM1

Other Studies

2 other study(ies) available for topotecan and Radiation Pneumonitis

ArticleYear
[Outcome of concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Cyclophosphamide; Esophagitis; Humans; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Topotecan

2015
[Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Survival Rate; Topotecan

2009